BBIO

76.0302.75%
FH

Fred Hassan

Lead Independent Director

Mr. Fred Hassan is Chair of the Board of Recursion Pharmaceuticals, Inc. from October 31, 2026. Mr. Hassan serves as Independent Director of EyePoint Pharmaceuticals, Inc since September 2024 and also has been its Lead Independent Director since April 2025. He serves as the Board Director of Caerus US 1, Inc. (also known as Norstella) and is its Executive Chair from February 2026. He serves as the Chairman of the Board at Saghmos Therapeutics, Inc. since October 2023. He serves as Independent Director at Cocrystal Pharma, Inc. since April 2023. He serves as an Independent Director of BridgeBio Pharma, Inc. since August 17, 2021. He serves as Director at Phil, Inc. since June 2021. He served as an Independent Director at Prometheus Biosciences, Inc. since May 14, 2021 until June 16, 2023. He serves as Scientific Advisor at Acurx Pharmaceuticals, Inc. He serves as the President of The International Federation of Pharmaceutical Manufacturers Association (IFPMA). He serves as a Director of Warburg Pincus LLC since September 2018. He served as a Special Limited Partner at the firm until 2018. He served as Managing Director, Managing Partner and Partner at the Warburg Pincus LLC since 2011 until July 2018. He joined Warburg Pincus in 2009 and advised the Healthcare Group and provides strategic counsel across its portfolio and served as its Senior Advisor from November 2009 through December 2010. He focused on healthcare and consumer sectors. He served as an Independent Director of Time Warner Inc. from October 29, 2009 to June 14, 2018. He serves as a Director of Novo Nordisk. He had been a Director of Amgen, Inc. July 28, 2015 until May 18, 2021. He has been a Director of Precigen, Inc. (formerly known as Intrexon Corporation) since June 30, 2016. He serves as a Member of Advisory Board at Caerus Ventures. He served as the Chairman and Chief Executive Officer of Schering-Plough Corporation from April 20, 2003 to November 3, 2009 and served as its President since April 20, 2003. He served as the Chairman and Chief Executive Officer of Merck & Co., Inc. He served as the Chairman of the Board of Pharmacia LLC from February 21, 2001 to 2003 and its served as its Chief Executive Officer from March 2000 to 2003 and President. He served as the Chief Executive Officer and President of Pharmacia & Upjohn Corporation from May 1997 to March 31, 2000. He served as the President of U.S. Operations at Wyeth LLC. He served as an Executive Vice President of Wyeth LLC from 1995 to May 1997, with responsibility for its pharmaceutical and medical products business. He served as a Senior Vice President from May 1993 to October 1995 and a Group Vice President from March 1993 to May 1993. He also served as the President of Wyeth-Ayerst Laboratories Division of American Home Products Corp. from 1989 to 1993. He served as the Chief Executive Officer, Chief Operating Officer and Corporate Vice President of Sandoz Pharmaceuticals Corporation from 1984 to 1989, spent as Headed its United States pharmaceuticals business. From 1972 to 1997, he served in various senior management roles at Novartis AG and other companies. He served as the Non-Executive Chairman of Avon Products Inc. from January 1, 2013 to April 26, 2013 and also served as its Lead Director since January 2011 and before that, served as its Presiding Director from 2007 to 2009. He served as the Chairman of Bausch & Lomb Holdings Incorporated since March 2010 until 2013. He served as the Chairman of Bausch & Lomb Incorporated since March 2010 and as its Director since November 2009. He served as a Director of Merck & Co., Inc. He served as a Director of Genetics Institute, LLC from 1991 to 1996, Pharmacia LLC since March 31, 2000, CIGNA Corp. from 2001 to 2003. He also served as the Director of Schering-Plough Corporation from April 22, 2003 to November 2009, HP Enterprise Services, LLC from February 2003 to October 2003, Avon Products Inc. from 1999 to April 26, 2013, Pharmacia & Upjohn LLC from 1997 to 2000, Valeant Pharmaceuticals International Inc from August 7, 2013 to May 20, 2014 and American Home Products Corporation from 1995 to May 1997. He was a Director at Modernizing Medicine, Inc. from May 10, 2017. He also serves as the Chief Executive Officer and Director of Schering-Plough Corporation from April 22, 2003 to November 2009. He served as the Chairman of The International Federation of Pharmaceutical Manufacturers Associations, The Pharmaceutical Research and Manufacturers of America (PhRMA) and the Healthcare Institute of New Jersey (HINJ). His book, “Reinvent, A Leader’s Playbook for Serial Success,” was published by Wiley in February 2013. He received an M.B.A. from Harvard Business School and a B.S. degree in Chemical Engineering from the Imperial College of Science and Technology at the University of London.

Positions